1
|
Xue Z, Zhu J, Liu J, Wang L, Ding J. Research progress of non-coding RNA in atrial fibrillation. Front Cardiovasc Med 2023; 10:1210762. [PMID: 37522088 PMCID: PMC10379658 DOI: 10.3389/fcvm.2023.1210762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 06/27/2023] [Indexed: 08/01/2023] Open
Abstract
Atrial fibrillation (AF) is a common arrhythmia in clinic, and its incidence is increasing year by year. In today's increasingly prevalent society, ageing poses a huge challenge to global healthcare systems. AF not only affects patients' quality of life, but also causes thrombosis, heart failure and other complications in severe cases. Although there are some measures for the diagnosis and treatment of AF, specific serum markers and targeted therapy are still lacking. In recent years, ncRNAs have become a hot topic in cardiovascular disease research. These ncRNAs are not only involved in the occurrence and development of AF, but also in pathophysiological processes such as myocardial infarction and atherosclerosis, and are potential biomarkers of cardiovascular diseases. We believe that the understanding of the pathophysiological mechanism of AF and the study of diagnosis and treatment targets can form a more systematic diagnosis and treatment framework of AF and provide convenience for individuals with AF and the society.
Collapse
|
2
|
Hao H, Dai C, Han X, Li Y. A novel therapeutic strategy for alleviating atrial remodeling by targeting exosomal miRNAs in atrial fibrillation. BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH 2022; 1869:119365. [PMID: 36167158 DOI: 10.1016/j.bbamcr.2022.119365] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2022] [Revised: 08/29/2022] [Accepted: 09/18/2022] [Indexed: 06/16/2023]
Abstract
Atrial fibrillation (AF) is one of the most frequent cardiac arrhythmias, and atrial remodeling is related to the progression of AF. Although several therapeutic approaches have been presented in recent years, the continuously increasing mortality rate suggests that more advanced strategies for treatment are urgently needed. Exosomes regulate pathological processes through intercellular communication mediated by microribonucleic acid (miRNA) in various cardiovascular diseases (CVDs). Exosomal miRNAs associated with signaling pathways have added more complexity to an already complex direct cell-to-cell interaction. Exosome delivery of miRNAs is involved in cardiac regeneration and cardiac protection. Recent studies have found that exosomes play a critical role in the diagnosis and treatment of cardiac fibrosis. By improving exosome stability and modifying surface epitopes, specific pharmaceutical agents can be supplied to improve tropism and targeting to cells and tissues in vivo. Exosomes harboring miRNAs may have clinical utility in cell-free therapeutic approaches and may serve as prognostic and diagnostic biomarkers for AF. Currently, limitations challenge pharmaceutic design, therapeutic utility and in vivo targeted delivery to patients. The aim of this article is to review the developmental features of AF associated with exosomal miRNAs and relate them to underlying mechanisms.
Collapse
Affiliation(s)
- Hongting Hao
- Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China
| | - Chenguang Dai
- Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China
| | - Xuejie Han
- Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China
| | - Yue Li
- Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China; NHC Key Laboratory of Cell Translation, Harbin Medical University, Heilongjiang 150001, China; Key Laboratory of Hepatosplenic Surgery, Harbin Medical University, Ministry of Education, Harbin 150001, China; Key Laboratory of Cardiac Diseases and Heart Failure, Harbin Medical University, Harbin 150001, China; Heilongjiang Key Laboratory for Metabolic Disorder & Cancer Related Cardiovascular Diseases, Harbin 150081, China; Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, Harbin, China.
| |
Collapse
|
3
|
Wang H, Jiang W, Hu Y, Wan Z, Bai H, Yang Q, Zheng Q. Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2021; 93:153774. [PMID: 34656066 DOI: 10.1016/j.phymed.2021.153774] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/25/2020] [Revised: 09/12/2021] [Accepted: 09/21/2021] [Indexed: 06/13/2023]
Abstract
PURPOSE To investigate the role and mechanism of quercetin in isoprenaline (ISO)-induced atrial fibrillation (AF). STUDY DESIGN Rat cardiac fibroblasts (RCFs) models and RCFs were used to explore the effect and underlying mechanism of quercetin in isoprenaline (ISO)-induced atrial fibrillation (AF) in vivo and in vitro by a series of experiments. METHODS Differentially expressed microRNAs were screened from human AF tissues using the GEO2R and RT-qPCR. The expressions of TGF-β/Smads pathway molecules (TGFβ1, TGFBR1, Tgfbr1, Tgfbr2, Smad2, Smad3, Smad4) in AF tissues were detected by RT-qPCR and Western blot. The relationships between miR-135b and genes (Tgfbr1, Tgfbr2, Smad2) were analyzed by Pearson correlation, TargetScan and dual-luciferase activity assay. RCFs induced by ISO were treated with quercetin (20 or 50 μM), miR-135b mimic and inhibitor, siTgfbr1 and their corresponding controls, then the cell viability was determined by MTT and the expressions of cyclin D1, α-SMA, collagen-related molecules, TGF-β/Smads pathway molecules, and miR-135b were measured by RT-qPCR and Western blot. ISO-induced rats were treated with quercetin (25 mg/kg/day) via gavage, miR-135b antagomir, agomir and their corresponding controls. The treated rats were used for the detection of miR-135b expression by RT-qPCR, histopathological observation by HE and Masson staining, and the detection of Col1A1 and fibronectin contents by immunohistochemical technique. RESULTS The expression of miR-135b was downregulated, and those of TGFBR1, TGFBR2, target genes of miR-135b were upregulated in human AF tissues and negatively regulated by miR-135b in RCFs. Through inhibiting TGF-β/Smads pathway via promoting miR-135b expression, quercetin treatment inhibited proliferation, myofibroblast differentiation and collagen deposition in ISO-treated RCFs, as evidenced by reduced expressions of cyclin D1, α-SMA, collagen-related genes and proteins, and alleviated fibrosis and collagen deposition of atrial tissues in ISO-treated rats. CONCLUSION Quercetin may alleviate AF by inhibiting fibrosis of atrial tissues through inhibiting TGF-β/Smads pathway via promoting miR-135b expression.
Collapse
Affiliation(s)
- Hongtao Wang
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Wei Jiang
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Yanchao Hu
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Zhaofei Wan
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Hongyuan Bai
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Qiang Yang
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China
| | - Qiangsun Zheng
- Department of Cardiology, The Second Affiliated Hospital of Xi'an JiaoTong University, China.
| |
Collapse
|
4
|
Xiang K, Akram M, Elbossaty WF, Yang J, Fan C. Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers. Heart Fail Rev 2021; 27:1211-1221. [PMID: 34251579 DOI: 10.1007/s10741-021-10142-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/05/2021] [Indexed: 12/21/2022]
Abstract
Atrial fibrillation (AF), the most common cardiac arrhythmia, is a global epidemic. AF can cause heart failure and myocardial infarction and increase the risk of stroke, disability, and thromboembolic events. AF is becoming increasingly ubiquitous and is associated with increased morbidity and mortality at higher ages, resulting in an increasing threat to human health as well as substantial medical and social costs. Currently, treatment strategies for AF focus on controlling heart rate and rhythm with medications to restore and maintain sinus rhythm, but this approach has limitations. Catheter ablation is not entirely satisfactory and does not address the issues underlying AF. Research exploring the mechanisms causing AF is urgently needed for improved prevention, diagnosis, and treatment of AF. Exosomes are small vesicles (30-150 nm) released by cells that transmit information between cells. MicroRNAs in exosomes play an important role in the pathogenesis of AF and are established as a biomarker for AF. In this review, a summary of the role of exosomes in AF is presented. The role of exosomes and microRNAs in AF occurrence, their therapeutic potential, and their potential role as clinical biomarkers is considered. A better understanding of exosomes has the potential to improve the prognosis of AF patients worldwide, reducing the global medical burden of this disease.
Collapse
Affiliation(s)
- Kun Xiang
- Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China
| | - Muhammad Akram
- Department of Eastern Medicine, Government College University Faisalabad, Faisalabad, Pakistan
| | | | - Jinfu Yang
- Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China
| | - Chengming Fan
- Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China.
| |
Collapse
|
5
|
Lv J, Zhang H, Gao Z, Zhang X, Huang X, Jia X. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression. Cancer Biomark 2021; 28:247-254. [PMID: 32390603 DOI: 10.3233/cbm-191323] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Gastric cancer is a prevalent malignant around the world. Aberrantly expression of microRNAs (miRNAs) contributes to the progression of tumors. The aim of this study was to investigate the expression and role of miR-892a in gastric cancer. METHODS A total of 119 gastric cancer patients were enrolled in this study. And the expression of miR-892a in gastric cancer tissues and cells was measured using RT-qPCR analysis. Kaplan-Meier plotter and multivariate Cox regression analysis were used to explore the prognostic value of miR-892a in gastric cancer. The biological function of miR-892a in gastric cancer cells was evaluated using CCK-8 assays and Transwell assays. RESULTS The expression of miR-892a was high-expressed in gastric cancer tissues and cells. The miR-892a expression was associated with tumor size, differentiation, lymph node metastasis, and TNM stages. Gastric cancer patients with high miR-892a expression showed a short overall survival rate. Overexpression of miR-892a promoted cell proliferation, migration, and invasion of gastric cancer cells. CONCLUSION miR-892a was upregulated and predictor of poor prognosis in gastric cancer patients. The miR-892a in gastric cancer cells significantly promoted cell proliferative, migratory, and invasive properties. Furthermore, miR-892a may be served as a prognostic marker as well as a therapeutic target for gastric cancer.
Collapse
Affiliation(s)
- Jingjing Lv
- Department of Pathology, Caoxian People's Hospital of Shandong, Heze, Shandong, China.,Department of Pathology, Caoxian People's Hospital of Shandong, Heze, Shandong, China
| | - Haitao Zhang
- Department of Pathology, Chengwuxian People's Hospital of Shandong, Heze, Shandong, China.,Department of Pathology, Caoxian People's Hospital of Shandong, Heze, Shandong, China
| | - Zhimei Gao
- Department of Pathology, Diseases in Caoxian Hospital of Traditional Chinese Medicine of Shandong, Heze, Shandong, China
| | - Xinyan Zhang
- Department of Clinical Laboratory, Caoxian Maternal and Child Health and Family Planning Service Center of Shandong, Heze, Shandong, China
| | - Xin Huang
- Department of Pathology, Caoxian People's Hospital of Shandong, Heze, Shandong, China
| | - Xiaojuan Jia
- Department of Pathology, Caoxian People's Hospital of Shandong, Heze, Shandong, China
| |
Collapse
|
6
|
Mesquita Dantas K, Tomé Rezende H, Menezes da Silva Junior A, Sobrinho H, Paulo Clark de Oliveira P. A Expressão e Implicação Clínica de miRNAs Plasmáticos em Pacientes com Fibrilação Atrial. JOURNAL OF CARDIAC ARRHYTHMIAS 2020. [DOI: 10.24207/jca.v32n4.111_pt] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Introdução: miRNA circulantes foram identificados como potenciais biomarcadores em arritmias cardíacas. Assim, pretende-se avaliar, em pacientes com fibrilação atrial (FA), a expressão de miRNAs no plasma, a sua repercussão clínica e seu fator prognóstico. Materiais e Métodos: plataformas PubMed, Cochrane e Google Scholar foram usadas como fonte de dados. Critérios de elegibilidade: miRNAs como biomarcadores diretos na expressão clínica da FA; todos idiomas. Última busca: 19/09/2019; excluídos estudos envolvendo outras comorbidades; foco farmacológico; em animais ;em pacientes já submetidos a procedimentos cardíacos e artigos de revisão. Nos estudos foram realizados a coleta e armazenamento de plasma, isolamento de RNA, análise de dados, PCR em tempo real, previsão de alvo do miRNA e análise estatística. Resultados: Os estudos analisados geraram um n=332 pacientes separados em: portadores de FA e grupo controle. Em pacientes com FA houve aumento da expressão do miR-1266, miR-4279, miR-892a, miR-3149, miR-155, miR-146b5p, miR-19b e redução de miR-3171, miR-3664-5p e miRNA-150. Discussão: notou-se que a regulação de mediadores inflamatórios, canais iônicos e morfofisiologia cardíaca estão relacionados com a expressão dos miRNA. Conclusão: logo, os níveis de alterações de miRNAs podem refletir a gravidade do avanço clínico e fisiopatológico da FA, podendo ser utilizados como preditores da FA.
Collapse
Affiliation(s)
- Kamilo Mesquita Dantas
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | - Heitor Tomé Rezende
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | | | - Hermínio Sobrinho
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | - Pedro Paulo Clark de Oliveira
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| |
Collapse
|
7
|
Mesquita Dantas K, Tomé Rezende H, Menezes da Silva Junior A, Sobrinho H, Paulo Clark de Oliveira P. The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation. JOURNAL OF CARDIAC ARRHYTHMIAS 2020. [DOI: 10.24207/jca.v32n4.111_in] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Introduction: circulating miRNA were identified as potential biomarkers in cardiac arrhythmias. It is intended to evaluate, in patients with atrial fibrillation (AF), the expression of miRNAs in plasma, their clinical repercussion and their prognostic factor. Materials and Methods: PubMed, Cochrane and Google Scholar platforms were used as a data source. Eligibility criteria: miRNAs as direct biomarkers in the clinical expression of AF; all languages. Last search: 19/09/2019; studies involving other comorbidities were excluded; pharmacological focus; in animals, in patients already submitted to cardiac procedures and review articles. Plasma collection and storage, RNA isolation, data analysis, realtime PCR, miRNA target prediction and statistical analysis were performed in the studies. Results: The studies generated n = 332 patients: with AF and control group. In patients with AF there was an increase in the expression of miR-1266, miR-4279, miR- 892a, miR-3149, miR-155, miR-146b5p, miR-19b and a reduction in miR-3171, miR-3664-5p and miRNA -150. Discussion: it was noted that the regulation of inflammatory mediators, ion channels and cardiac morphophysiology are related to the expression of miRNA. Conclusion: Therefore, the levels of changes in miRNAs may reflect the severity of the clinical and pathophysiological progression of AF, and can be used as predictors of AF.
Collapse
Affiliation(s)
- Kamilo Mesquita Dantas
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | - Heitor Tomé Rezende
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | | | - Hermínio Sobrinho
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| | - Pedro Paulo Clark de Oliveira
- Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil
| |
Collapse
|
8
|
Ben‐Zvi I, Volinsky N, Grosman‐Rimon L, Haviv I, Rozen G, Andria N, Asulin N, Margalit N, Marai I, Amir O. Cardiac-peripheral transvenous gradients of microRNA expression in systolic heart failure patients. ESC Heart Fail 2020; 7:835-843. [PMID: 32253819 PMCID: PMC7261589 DOI: 10.1002/ehf2.12597] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Revised: 10/20/2019] [Accepted: 11/25/2019] [Indexed: 12/28/2022] Open
Abstract
Aims The aims of the study are to assess the levels of coronary sinus (CS) miRNAs of systolic heart failure (HF) patients in samples obtained during cardiac resynchronization therapy (CRT) device implantation and compare them to the peripheral systemic venous miRNA expression. Methods and Results The cardiac specific miRNA levels were assessed in 60 patients, 39 HF patients with reduced ejection fraction and 21 control patients. The levels of four cardiac specified miRNAs (miR‐21‐5p, miR‐92b‐3p, miR‐125b‐5p, and miR‐133a‐3p) were compared between the peripheral samples of HF and controls and between peripheral venous in CS in the HF groups. Compared with controls, HF patients had higher peripheral serum venous levels of miR‐125b‐5p and miR‐133‐3p. In the HF group, the levels of expression were higher for miR‐125b‐5p and lower for miR‐92, and miR‐21‐5p in the CS, compared with the peripheral venous circulation. Conclusions The differences in miRNA expressions in CS compared with those in the periphery suggest that changes that may occur at the levels of the myocardial tissue in HF may be more relevant to our understanding of the biological linkage between miRNA expression and HF, than the traditional analysis of systemic serum miRNA expression.
Collapse
Affiliation(s)
- Inbar Ben‐Zvi
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Natalia Volinsky
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Liza Grosman‐Rimon
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Izhak Haviv
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Guy Rozen
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
- Cardiac Arrhythmia ServiceMassachusetts General HospitalBostonMAUSA
| | - Nizar Andria
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Nofar Asulin
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Nufar Margalit
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
| | - Ibrahim Marai
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| | - Offer Amir
- Cardiovascular Department and Research CenterBaruch Padeh Medical CenterTiberiasIsrael
- The Azrieli Faculty of Medicine in the GalileeBar‐Ilan UniversitySafedIsrael
| |
Collapse
|
9
|
Abstract
Coronary artery disease (CAD) is the second leading cause of death after stroke in China. Percutaneous coronary intervention (PCI) significantly improves the prognosis of CAD patients. This study aimed to evaluate the diagnostic value of circulating microRNAs (miRNAs) in patients with severe CAD requiring PCI. The plasma miRNA profiles were determined using miRNA microarray. The relative expression levels of differentially expressed miRNA were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Nine miRNAs (ebv-miR-BART12, ebv-miR-BART16, let-7i-5p, miR-130a-3p, miR-26a-5p, miR-3149, miR-3152-3p, miR-32-3p, and miR-149-3p) were differentially expressed between severe CAD and control groups. Four miRNAs (let-7i-5p, miR-32-3p, miR-3149, and miR-26a-5p) validated by qRT-PCR showed good diagnostic accuracy, with the area under the receiver operating characteristic curves (AUCs) of 0.634 (95% confidence interval [CI] 0.528-0.739), 0.745 (95%CI 0.649-0.84), 0.795 (95%CI 0.709-0.88), and 0.818 (95%CI 0.739-0.897), respectively. Furthermore, the combination of these 4 miRNAs exhibited better diagnostic performance compared with any individual miRNA, with an AUC of 0.837 (95%CI 0.763-0.911). These data indicate that plasma let-7i-5p, miR-32-3p, miR-3149, and miR-26a-5p have promising diagnostic value for severe CAD.
Collapse
Affiliation(s)
- Xuelin Zhang
- Department of Vascular Surgery, the Second Affiliated Hospital of Suzhou University, Suzhou
| | | | | | | | - Shanan Lin
- Department of Cardiothoracic Surgery, Taizhou Central Hospital, Taizhou, Zhejiang
| | - Xiaoqiang Li
- Department of Vascular Surgery, the Second Affiliated Hospital of Suzhou University, Suzhou
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
| |
Collapse
|
10
|
Shen NN, Zhang C, Li Z, Kong LC, Wang XH, Gu ZC, Wang JL. MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis. Exp Biol Med (Maywood) 2019; 245:42-53. [PMID: 31766887 DOI: 10.1177/1535370219890303] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Association between microRNA (miRNA) expression signatures and atrial fibrillation has been evaluated with inconsistent findings in different studies. This study aims to identify miRNAs that actually play vital role in pathophysiological process of atrial fibrillation and explore miRNA-targeted genes and the involved pathways. Relevant studies were retrieved from the electronic databases of Embase, Medline, and Cochrane Library to determine the miRNA expression profiles between atrial fibrillation subjects and non-atrial fibrillation controls. Robustness of results was assessed using sensitivity analysis. Subgroup analyses were performed based on species, miRNA detection method, sample source, and ethnicity. Quality assessment of studies was independently conducted according to QUADAS-2. Bioinformatics analysis was applied to explore the potential genes and pathways associated with atrial fibrillation, which were targeted by differentially expressed miRNAs. Form of pooled results was shown as log10 odds ratios (logORs) with 95% confidence intervals (CI), and random-effects model was used. In total, 40 articles involving 283 differentially expressed miRNAs were reported. And 51 significantly dysregulated miRNAs were identified in consistent direction, with 22 upregulated and 29 downregulated. Among above-mentioned miRNAs, miR-223-3p (logOR 6.473; P < 0.001) was the most upregulated, while miR-1-5p (logOR 7.290; P < 0.001) was the most downregulated. Subgroup analysis confirmed 53 significantly dysregulated miRNAs (21 upregulated and 32 downregulated) in cardiac tissue, with miRNA-1-5p and miRNA-223-3p being the most upregulated and downregulated miRNAs, respectively. Additionally, miR-328 and miR-1-5p were highly blood-specific, and miR-133 was animal-specific. In the detection method sub-groups, miRNA-29b and miRNA-223-3p were differentially expressed consistently. Four miRNAs, including miRNA-223-3p, miRNA-21, miRNA-328, and miRNA-1-5p, were consistently dysregulated in both Asian and non-Asian. Results of sensitivity analysis showed that 47 out of 51 (92.16%) miRNAs were dysregulated consistently. Totally, 51 consistently dysregulated miRNAs associated with atrial fibrillation were confirmed in this study. Five important miRNAs, including miR-29b, miR-328, miR-1-5p, miR-21, and miR-223-3p may act as potential biomarkers for atrial fibrillation. Impact statement Atrial fibrillation (AF) is considered as the most common arrhythmia, and it subsequently causes serious complications including thrombosis and heart failure that increase the social burden. The definite mechanisms underlying AF pathogenesis remain complicated and unclear. Many studies attempted to discover the transcriptomic changes using microarray technologies, and the present studies for this hot topic have assessed individual miRNAs profiles for AF. However, results of different articles are controversial and not each reported miRNA is actually associated with the pathogenesis of AF. The present systematic review and meta-analysis identified that 51 consistently dysregulated miRNAs were associated with AF. Of these miRNAs, five miRNAs (miRNA-1-5p, miRNA-328, miRNA-29b, miRNA-21, and miRNA-223-3p) may act as novel biomarkers for AF. The findings could offer a better description of the biological characteristics of miRNAs, meanwhile might serve as new target for the intervention and monitoring AF in future studies.
Collapse
Affiliation(s)
- Nan-Nan Shen
- Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shao Xing 312000, China.,State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Chi Zhang
- State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Zheng Li
- Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Ling-Cong Kong
- Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Xin-Hua Wang
- Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Zhi-Chun Gu
- State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
| | - Jia-Liang Wang
- Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shao Xing 312000, China
| |
Collapse
|
11
|
Shen NN, Zhang ZL, Li Z, Zhang C, Li H, Wang JL, Wang J, Gu ZC. Identification of microRNA biomarkers in atrial fibrillation: A protocol for systematic review and bioinformatics analysis. Medicine (Baltimore) 2019; 98:e16538. [PMID: 31348272 PMCID: PMC6708903 DOI: 10.1097/md.0000000000016538] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Atrial fibrillation (AF) is recognized as the most prevalent arrhythmia, and its subsequently serious complications of heart failure and thromboembolism always raise the social attention. To date, the molecular pathogenesis of AF has largely remained unclear. Publications of contemporary studies have evaluated individual miRNAs expression signatures for AF, and findings of different studies are inconsistent and not all miRNAs reported are actually important in the pathogenesis of AF. METHODS Medline, Embase, and Cochrane Library databases will be comprehensively searched (up to April 30, 2019) for studies identifying miRNA expression profiling in subjects with and without AF. Log10 odds ratios (logORs) and associated 95% confidence interval (95%CI) will be calculated using random-effects models. Subgroup analysis will be performed according to miRNA detecting methods, species, sample types, and ethnicities. Sensitivity analysis will be conducted to detect the robustness of the findings. The methodological quality of studies will be independently assessed using criteria adopted from the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Furthermore, bioinformatics analysis will be performed to identify the potential target genes in AF and the corresponding pathways of dysregulated miRNAs. Two reviewers will independently screen potential studies and extract data in a structured eligibility items, with any disagreements being resolved by consensus. RESULTS The present systematic review will identify potential biomarkers by pooling all differentially expressed miRNAs in AF studies, as well as to predict miRNA-target interactions and to identify the potential biometric functions using bioinformatics analysis. CONCLUSIONS This systematic review and bioinformatics analysis will identify several miRNAs as potential biomarkers for AF, and explore the biological pathways regulated by the eligible miRNAs. PROSPERO REGISTRATION NUMBER CRD42019127594.
Collapse
Affiliation(s)
- Nan-Nan Shen
- Department of Pharmacy
- Department of Geriatrics, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang Province
- Department of Pharmacy
| | | | - Zheng Li
- Department of Cardiology, Renji Hospital
| | | | - Hao Li
- Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China
| | - Jia-Liang Wang
- Department of Pharmacy
- Department of Geriatrics, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang Province
| | - Jun Wang
- Department of Pharmacy
- Department of Geriatrics, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang Province
| | | |
Collapse
|
12
|
Jiang S, Guo C, Zhang W, Che W, Zhang J, Zhuang S, Wang Y, Zhang Y, Liu B. The Integrative Regulatory Network of circRNA, microRNA, and mRNA in Atrial Fibrillation. Front Genet 2019; 10:526. [PMID: 31249590 PMCID: PMC6584754 DOI: 10.3389/fgene.2019.00526] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Accepted: 05/14/2019] [Indexed: 01/29/2023] Open
Abstract
Atrial fibrillation (AF) is the most common irregular heart rhythm which influence approximately 1–2% of the general population. As a potential factor for ischemic stroke, AF could also cause heart failure. The mechanisms behind AF pathogenesis is complex and remains elusive. As a new category of non-coding RNAs (ncRNAs), circular RNAs (circRNAs) have been known as the key of developmental processes, regulation of cell function, pathogenesis of heart diseases and pathological responses which could provide novel sight into the pathogenesis of AF. circRNAs function as modulators of microRNAs in cardiac disease. To investigate the regulatory mechanism of circRNA in AF, especially the complex interactions among circRNA, microRNA and mRNA, we collected the heart tissues from three AF patients and three healthy controls and profiled their circRNA expressions with circRNA Microarray. The differentially expressed circRNAs were identified and the biological functions of their interaction microRNAs and mRNAs were analyzed. Our results provided novel insights of the circRNA roles in AF and proposed highly possible interaction mechanisms among circRNAs, microRNAs, and mRNAs.
Collapse
Affiliation(s)
- Shengyang Jiang
- Department of Cardiology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Changfa Guo
- Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Wei Zhang
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| | - Wenliang Che
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.,Department of Cardiology, Shanghai Tenth People's Hospital Chongming Branch, Tongji University School of Medicine, Shanghai, China
| | - Jie Zhang
- Key Laboratory of Arrhythmias, Ministry of Education, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
| | - Shaowei Zhuang
- Department of Cardiology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - Yiting Wang
- Key Laboratory of Arrhythmias, Ministry of Education, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.,Basic Medical College, Jinzhou Medical University, Jinzhou, China
| | - Yangyang Zhang
- Key Laboratory of Arrhythmias, Ministry of Education, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.,Department of Cardiovascular Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
| | - Ban Liu
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China
| |
Collapse
|
13
|
Mun D, Kim H, Kang J, Park H, Park H, Lee S, Yun N, Joung B. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation. FASEB J 2019; 33:5979-5989. [DOI: 10.1096/fj.201801758r] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Dasom Mun
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| | - Hyoeun Kim
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| | - Ji‐Young Kang
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| | - Hyelim Park
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| | - Hyewon Park
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| | - Seung‐Hyun Lee
- Department of Biochemistry and Molecular BiologyYonsei University College of Medicine Seoul South Korea
| | - Nuri Yun
- Institute of Life Science and BiotechnologyYonsei University Seoul South Korea
| | - Boyoung Joung
- Division of CardiologyYonsei University College of Medicine Seoul South Korea
| |
Collapse
|
14
|
Gu H, Chen L, Xue J, Huang T, Wei X, Liu D, Ma W, Cao S, Yuan Z. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects. Biomed Pharmacother 2019; 109:823-830. [DOI: 10.1016/j.biopha.2018.10.110] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2018] [Revised: 10/06/2018] [Accepted: 10/20/2018] [Indexed: 01/08/2023] Open
|
15
|
The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases. Acta Pharmacol Sin 2018; 39:1085-1099. [PMID: 29877319 DOI: 10.1038/aps.2018.35] [Citation(s) in RCA: 77] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2017] [Accepted: 01/20/2018] [Indexed: 12/21/2022] Open
Abstract
Pervasive transcription of the human genome is responsible for the production of a myriad of non-coding RNA molecules (ncRNAs) some of them with regulatory functions. The pivotal role of ncRNAs in cardiovascular biology has been unveiled in the last decade, starting from the characterization of the involvement of micro-RNAs in cardiovascular development and function, and followed by the use of circulating ncRNAs as biomarkers of cardiovascular diseases. The human non-coding secretome is composed by several RNA species that circulate in body fluids and could be used as biomarkers for diagnosis and outcome prediction. In cardiovascular diseases, secreted ncRNAs have been described as biomarkers of several conditions including myocardial infarction, cardiac failure, and atrial fibrillation. Among circulating ncRNAs, micro-RNAs (miRNAs), long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have been proposed as biomarkers in different cardiovascular diseases. In comparison with standard biomarkers, the biochemical nature of ncRNAs offers better stability and flexible storage conditions of the samples, and increased sensitivity and specificity. In this review we describe the current trends and future prospects of the use of the ncRNA secretome components as biomarkers of cardiovascular diseases, including the opening questions related with their secretion mechanisms and regulatory actions.
Collapse
|
16
|
Meydan C, Bekenstein U, Soreq H. Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk. Front Mol Neurosci 2018; 11:189. [PMID: 29922126 PMCID: PMC5996041 DOI: 10.3389/fnmol.2018.00189] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2018] [Accepted: 05/15/2018] [Indexed: 01/04/2023] Open
Abstract
Sepsis and metabolic syndrome (MetS) are both inflammation-related entities with high impact for human health and the consequences of concussions. Both represent imbalanced parasympathetic/cholinergic response to insulting triggers and variably uncontrolled inflammation that indicates shared upstream regulators, including short microRNAs (miRs) and long non-coding RNAs (lncRNAs). These may cross talk across multiple systems, leading to complex molecular and clinical outcomes. Notably, biomedical and RNA-sequencing based analyses both highlight new links between the acquired and inherited pathogenic, cardiac and inflammatory traits of sepsis/MetS. Those include the HOTAIR and MIAT lncRNAs and their targets, such as miR-122, −150, −155, −182, −197, −375, −608 and HLA-DRA. Implicating non-coding RNA regulators in sepsis and MetS may delineate novel high-value biomarkers and targets for intervention.
Collapse
Affiliation(s)
- Chanan Meydan
- Department of Internal Medicine, Mayanei Hayeshua Medical Center, Bnei Brak, Israel
| | - Uriya Bekenstein
- The Department of Biological Chemistry, The Edmond and Lilly Safra Center for Brain Sciences, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
| | - Hermona Soreq
- The Department of Biological Chemistry, The Edmond and Lilly Safra Center for Brain Sciences, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
| |
Collapse
|
17
|
Su Y, Li L, Zhao S, Yue Y, Yang S. The long noncoding RNA expression profiles of paroxysmal atrial fibrillation identified by microarray analysis. Gene 2018; 642:125-134. [DOI: 10.1016/j.gene.2017.11.025] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2017] [Revised: 10/28/2017] [Accepted: 11/08/2017] [Indexed: 12/11/2022]
|